Consumers' Knowledge, Attitudes, and Practices Toward Medicine Price Transparency at Private Healthcare Setting in Malaysia
Bibliographic Data
| ID | 22090889 |
|---|---|
| Authors | Nur Sufiza Ahmad (0000-0001-7962-4462, Ministry of Health), Ernieda Hatah (0000-0002-6300-2965, National University of Malaysia, corresponding author), Mohamad Ridha Jalil (National University of Malaysia), Mohd Makmor-Bakry, Mohd Makmor‐Bakry (0000-0002-0592-0645, National University of Malaysia) |
| Year | 2021 |
| Volume | 9 |
| Pages | 589734-589734 |
| Publication date | 2021-08-24 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2296-2565 • E-ISSN: 2296-2565 |
| Publisher | Frontiers Media SA (PUBLISHER • CH) |
| DOI | 10.3389/fpubh.2021.589734 |
| PMID | 34504820 |
| OpenAlex | W3194261275 |
| Language | EN |
| Citations received | 2 |
| References cited | 18 |
Background: Medicine price transparency refers to the practice of making prices available to consumers for them to identify, compare, and select the medicine that provides the desired value. This study aimed to evaluate consumer knowledge, attitudes, and practices regarding Malaysia's medicine price transparency initiative, as well as factors that may influence related good consumer practices in private healthcare settings. Methods: A cross-sectional, self-administered survey was conducted between May and July 2019 among consumers attending private healthcare institutions in Malaysia. The self-developed and validated survey consisted of four sections on the following: respondents' demographics, and 28 close-ended and graded Likert scale answer options on knowledge, attitudes, and practices toward medicine price transparency. Factors influencing good consumer practices toward the transparency initiative were modeled using binary logistic regression. Results: A total of 679 respondents were part of the study. The mean age of respondents was 38 ± 13.3, with the majority ( n = 420, 61.9%) being female. The respondents' mean score of knowledge and attitudes toward the price transparency initiative was 5.6 ± 1.5 of the total score of 8 and 31.9 ± 4.0 of the total score of 40, respectively. The respondents had the lowest score in the practice of price transparency, with a mean score of 31.5 ± 5.6 of the total score of 60. Male gender, Chinese ethnicity, high score on knowledge and attitudes, and high expenses on medicines influenced respondents' good practices of medicine price transparency. Conclusion: Respondents had good knowledge and attitudes, but their usage and implementation of the medicine price transparency initiative was still inadequate. A number of factors influence this inadequacy, including gender, race, consumers' out-of-pocket spending on medication, and knowledge of and attitudes toward price transparency practices. Consumer-driven market price control would be impossible to achieve without the good consumer practices of medicine price transparency
Business · Cross-sectional study · Economics · Family medicine · Health care · Likert scale · Logistic regression · Political science · Health Systems, Economic Evaluations, Quality of Life · Healthcare Systems and Reforms · Medicine · Pharmaceutical Economics and Policy · Psychology · Marketing
Methodology series module 3
Design and Implementation Content Validity Study
Purposeful selection of variables in logistic regression
Enhancing medicine price transparency through price information mechanisms
Who Uses a Price Transparency Tool? Implications for Increasing Consumer Engagement
Access to medicines
| Citations per year | 0.67 |
|---|---|
| Citation span | 2023 - 2026 (4) |
| Highly cited | No |